Growth Metrics

Arrowhead Pharmaceuticals (ARWR) Goodwill & Intangibles (2016 - 2025)

Arrowhead Pharmaceuticals' Goodwill & Intangibles history spans 15 years, with the latest figure at $6.4 million for Q4 2025.

  • For Q4 2025, Goodwill & Intangibles fell 20.9% year-over-year to $6.4 million; the TTM value through Dec 2025 reached $6.4 million, down 20.9%, while the annual FY2025 figure was $6.9 million, 19.87% down from the prior year.
  • Goodwill & Intangibles reached $6.4 million in Q4 2025 per ARWR's latest filing, down from $6.9 million in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $14.5 million in Q1 2021 to a low of $6.4 million in Q4 2025.
  • Average Goodwill & Intangibles over 5 years is $10.5 million, with a median of $10.5 million recorded in 2023.
  • Peak YoY movement for Goodwill & Intangibles: decreased 10.49% in 2021, then decreased 20.9% in 2025.
  • A 5-year view of Goodwill & Intangibles shows it stood at $13.2 million in 2021, then decreased by 12.85% to $11.5 million in 2022, then dropped by 14.74% to $9.8 million in 2023, then fell by 17.28% to $8.1 million in 2024, then dropped by 20.9% to $6.4 million in 2025.
  • Per Business Quant, the three most recent readings for ARWR's Goodwill & Intangibles are $6.4 million (Q4 2025), $6.9 million (Q3 2025), and $7.3 million (Q2 2025).